Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance
- 1 September 2000
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 33 (3) , 469-475
- https://doi.org/10.1016/s0168-8278(00)80284-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Therapy of Viral HepatitisDigestion, 1998
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- Global status of hepatitis B immunisationThe Lancet, 1996
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gammaAntimicrobial Agents and Chemotherapy, 1992
- Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.Published by Elsevier ,1992
- Natural History and Control of Perinatally Acquired Hepatitis B Virus InfectionDigestive Diseases, 1992
- Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.Proceedings of the National Academy of Sciences, 1991
- Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analogAntimicrobial Agents and Chemotherapy, 1991
- Hepatitis B: global importance and need for controlVaccine, 1990